Grantham, Mayo, Van Otterloo & Co (GMO)’s Belden BDC Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio BDC Stock Details BDC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,197	Closed	-$788K	–	516
2023 Q4	$788K	Sell	10,197 -21,582	-68%	-$1.6M	﹤0.01%	387
2023 Q3	$3.07M	Sell	31,779 -16,723	-34%	-$1.56M	0.01%	363
2023 Q2	$4.64M	Buy	48,502 +19,902	+70%	+$1.7M	0.02%	340
2023 Q1	$2.48M	Buy	+28,600	New	+$2.37M	0.01%	400
2019 Q4	–	Sell	-23,600	Closed	-$1.26M	–	690
2019 Q3	$1.26M	Buy	+23,600	New	+$1.18M	0.01%	510
2018 Q2	–	Sell	-12,900	Closed	-$889K	–	556
2018 Q1	$889K	Sell	12,900 -22,200	-63%	-$1.7M	0.01%	385
2017 Q4	$2.71M	Buy	+35,100	New	+$2.9M	0.02%	299

Other funds holding BDC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s BDC Position: Q1 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Belden (BDC) in Q1 2024, closing a stake of 10,197 shares — an estimated $788K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BDC in Q4 2017 and held it in 7 quarters. The position peaked at $4.64M in Q2 2023. 281 funds tracked by Wall St. Rank hold BDC as of Q1 2024.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Belden position as of Q1 2024 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,197 Belden shares in Q1 2024, an estimated $788K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Belden in Q4 2017 and held it in 7 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Belden position peaked at $4.64M in Q2 2023.
281 funds tracked by Wall St. Rank held Belden as of Q1 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2024, filed 14 May 2024.